Diagnosis and Treatment of Psoriasis

Authors

  • Muhammad Rafi Eka Putra 082283163684
  • Dwi Indria Anggraini
  • Syahrul Hamidi Nasution
  • Hendra Tarigan Sibero

DOI:

https://doi.org/10.53089/medula.v13i2.656

Keywords:

Diagnosis, Treatment, Psoriasis

Abstract

Psoriasis is a chronic skin inflammation characterized by clear erythematous plaques, rough scales, and layered silvery white plaques, especially on the elbows, knees, scalp, back, umbilicus, and lumbar region. 125 million people worldwide have psoriasis, with prevalence varying in different countries. Psoriasis has a prevalence of 1% to 3% in Europe and the United States. Psoriasis is a disease caused by an autoimmune condition. The diagnosis of psoriasis can be made based on the clinical picture. The physical examination should include examination of the primary lesion and other common areas affected by psoriasis including the scalp. A family history should be asked to support the diagnosis. The diagnosis can also be established by the presence of candle drip phenomenon, auspitz and kobner (isomorphic) which are symptoms of psoriasis. In addition, a histopathological examination can also be performed with a picture of hyperkeratosis, parakeratosis, acanthosis, Munro's abscess, papillomatosis and vasodilatation subepidermis. Psoriasis therapy is given topically in mild degrees and systemic therapy and phototherapy are given in moderate to severe psoriasis. Topical therapy that can be given is corticosteroids, vitamin D analogues, retinoids, TAR (LCD 3-10%), keratolytics (salicylic acid), and emollients. Systemic therapy used in moderate to severe cases includes acitretin, methotrexate, cyclosporin. Commonly used autotherapy in the treatment of psoriasis are narrowband ultraviolet B (NB-UVB), broadband ultraviolet B (BB-UVB), and topical 8-methoxypsoralen and UVA (PUVA).

References

Menaldi S, Bramono K, Indriatmi W, eds. Ilmu Penyakit Kulit Dan Kelamin. 7th ed. FKUI; 2016.

Michelle A. Lowes, Chris B. Russell, David A. Martin, Jennifer E. Towne and JG, Krueger. Keratinocyte Responses. Trends Immunol. 2014;34(4):174-181. doi:10.1016/j.it.2012.11.005.

Sutanto NR, Budianti WK. Perkembangan Terkini Terapi Sistemik Psoriasis Current Systemic Therapy for Psoriasis. J Kedokt Meditek. 2021;27(2):136-146.

Brandon A, Mufti A, Gary Sibbald R. Diagnosis and management of cutaneous psoriasis: A review. Adv Ski Wound Care. 2019;32(2):58-69. doi:10.1097/01.ASW.0000550592.08674.43

Dand N, Mucha S, Tsoi LC, et al. Exome-wide association study reveals novel psoriasis susceptibility locus at TNFSF15 and rare protective alleles in genes contributing to type I IFN signalling. Hum Mol Genet. 2017;26(21):4301-4313. doi:10.1093/hmg/ddx328

Umezawa Y, Ozawa A. Psoriasis vulgaris. Ryoikibetsu Shokogun Shirizu. 2000;2(31):293-295. doi:10.1007/978-3-642-44980-2_21

Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller A, Leffell D. Fitzpatrick’s Dermatology in General Medicine. 7th ed. McGraw-Hill Companies; 2008.

Gooderham MJ, Papp KA, Lynde CW. Shifting the focus – the primary role of IL-23 in psoriasis and other inflammatory disorders. J Eur Acad Dermatology Venereol. 2018;32(7):1111-1119. doi:10.1111/jdv.14868

Ladizinski B, Lee KC, Wilmer E, Alavi A, Mistry N, Sibbald RG. A review of the clinical variants and the management of psoriasis. Adv Ski Wound Care. 2013;26(6):271-284. doi:10.1097/01.ASW.0000429778.10020.67

Aprilliana KF, Mutiara H. Psoriasis Vulgaris Pada Laki-laki 46 Tahun. J Fak Kedokt Univ Lampung. 2017;4:160-166.

Kelly A, Taylor S, eds. Dermatology For Skin Of Color. McGraw-Hill Companies; 2009.

Novianto E, Fitri EM, Budianti WK, eds. Alur Tata Laksana Psoriasis Vulgaris (Tipe Plak) di Indonesia. In: 1st ed. Perhimpunan Dokter Spesialis Kulit dan Kelamin Indonesia; 2019.

Sbidian E, Chaimani A, Garcia-Doval I, et al. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis (Review). Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD011535.pub2.

Dewi FDK. Terapi pada Psoriasis. J Med Hutama. 2021;02(02):631-641. http://www.jurnalmedikahutama.com/index.php/JMH/article/view/145

Ashar D, Hsi Y, Hsuan Y, Eunyoung C. All-Cause And Causespecific Mortality In Psoriasis: A Systematic Review And Meta-Analysis. J Am Acad Dermatol. 2019;1(1):1332-1343. doi:10.1016/j.jaad.2018.12.037

Li SJ, Perez-Chada LM, Merola JF. TNF Inhibitor-Induced Psoriasis: Proposed Algorithm for Treatment and Management. J Psoriasis Psoriatic Arthritis. 2019;4(2):70-80. doi:10.1177/2475530318810851

Matos T, Ling T, Sheth V. Ultraviolet B radiation therapy for psoriasis: Pursuing the optimal regime. 2016;34(5):587-593. doi:10.1016/j.clindermatol.2016.05.008

Tampa M, Sarbu MI, Mitran MI, Mitran CI, Matei C, Georgescu SR. The Pathophysiological Mechanisms and the Quest for Biomarkers in Psoriasis, a Stress-Related Skin Disease. Dis Markers. 2018;2018. doi:10.1155/2018/5823684

Published

2023-02-18

How to Cite

Muhammad Rafi, Anggraini, D. I., Nasution, S. H., & Sibero, H. T. (2023). Diagnosis and Treatment of Psoriasis. Medical Profession Journal of Lampung, 13(2), 164-170. https://doi.org/10.53089/medula.v13i2.656

Issue

Section

Artikel

Most read articles by the same author(s)